Active substance · J07BH01
Rotavirus vaccine live, oral, attenuated
Classification
- Anatomical main groupJAnti-infectives for systemic use
- Therapeutic subgroupJ07
- Pharmacological subgroupJ07B
- Chemical subgroupJ07BH
- Chemical substanceJ07BH01Rota virus, live attenuated
Where it is registered
Each register with its number of medicines and a few of them.
Canada
Health Canada · 1 medicine
All medicines with Rotavirus vaccine live, oral, attenuated
Every register, a page at a time. Strengths and packs are on each medicine’s page.
6 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Rotarix | Canada | 1000000 CCID50 / 1.5 ML | Suspension | Marketed | Glaxosmithkline INC |
| Rubella Virus Vaccine Live Dried Attenuated | Canada | 1000 UNIT / 0.5 ML | Powder For Solution | Cancelled | Aventis Pasteur Limited |
| Rotarix Oral VaccineCombination | Saudi Arabia | Authorised | Glaxosmithkline (GSK) | ||
| Measles Virus Vaccine, Live, Attenuated(Dried)Combination | Taiwan | 注射劑 | Cancelled | 法台化學股份有限公司 | |
| Measles Virus Vaccine, Live, Attenuated (Dried)Combination | Canada | 1000 UNIT / KIT + 0.6 ML / KIT | Kit, Liquid, Powder For Solution | Cancelled | Connaught Laboratories LTD. |
| Rotarix Oral Suspension VaccineCombination | Saudi Arabia | Authorised | Glaxosmithkline (GSK) |



